Researchers Determine Effective Therapeutic Candidates for Crimean-Congo Hemorrhagic Fever
source: pixabay.com

Researchers Determine Effective Therapeutic Candidates for Crimean-Congo Hemorrhagic Fever

Endemic in areas of Africa, southeast Europe, Central Asia, and the Middle East, Crimean-Congo hemorrhagic fever is an often-fatal viral illness which can cause severe issues. Researchers estimate that this…

Continue Reading Researchers Determine Effective Therapeutic Candidates for Crimean-Congo Hemorrhagic Fever

Phase 3 Investigation of Ampreloxetine Produces Positive Results for Neurogenic Orthostatic Hypotension

Theravance Biopharma Inc. has just released results from their 2nd Phase 3 investigation of Ampreloxetine as a therapy for symptomatic neurogenic orthostatic hypotension (nOH). Symptomatic nOH NOH is a rare…

Continue Reading Phase 3 Investigation of Ampreloxetine Produces Positive Results for Neurogenic Orthostatic Hypotension

Advocates Ask that the Same Effort Used for COVID Drug Discovery Be Used for Rare Diseases

Dr. Christopher Austin, a National Institute of Health Director for Transitional Sciences, spoke at last year’s virtual conference honoring Rare Disease Day. According to an article in the NIH Record, Dr.…

Continue Reading Advocates Ask that the Same Effort Used for COVID Drug Discovery Be Used for Rare Diseases

Study Identifies People with Idiopathic Pulmonary Arterial Hypertension at Greatest Risk of Death

Korea began its use of effective therapies for idiopathic pulmonary arterial hypertension (IPAH) early in 2000. Idiopathic hypertension has no apparent cause. Yet there have been very few studies assessing…

Continue Reading Study Identifies People with Idiopathic Pulmonary Arterial Hypertension at Greatest Risk of Death
TNF Inhibitors Do Not Increase Dementia Risk in Patients with RA
Rheumatoid arthritis. Source: James Heilman, MD / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

TNF Inhibitors Do Not Increase Dementia Risk in Patients with RA

In the past, certain research has suggested a relationship between the use of therapies like TNF inhibitors, tocilizumab, and tofacitinib, and a heightened risk of Alzheimer’s disease (AD) or dementia.…

Continue Reading TNF Inhibitors Do Not Increase Dementia Risk in Patients with RA